IL6 and atherosclerosis: In addition, during the course of AS, IL-6 interacts with the hypothalamic-pituitary-adrenal (HPA) axis, leading to traditional cardiovascular risk factors including decreased insulin sensitivity, increased BMI, and the occurrence of hypertension (Boyer et al., 2012), exacerbating atherosclerosis.